Simulations Plus leverages AI-driven tools to revolutionize drug discovery, cut R&D costs, and capitalize on FDA regulatory ...

The question is not whether AI will transform healthcare; it’s whether regulators can keep pace with that transformation.

Experts express concern that last week's unprecedented FDA layoffs will trigger a little-known mechanism that could result in ...

The FDA has announced plans to phase out animal testing in the development of monoclonal antibodies and other drugs.

Indian benchmark indices, Sensex and Nifty, surged nearly 2% to end in the green after the U.S. paused steep reciprocal ...

The U.S. Food and Drug Administration said on Thursday it plans to replace animal testing in the development of monoclonal ...

Surgical technology company Proprio earned its second major FDA 510(k) clearance to include intraoperative measurements for ...

Proprio, a Seattle startup using artificial intelligence for improved surgical precision, received its second major clearance from the ...

Having won US Food & Drug Administration approval for its nerve repair agent Remplir, Orthocell is wasting no time getting it ...

A steep 27% US tariff threatens India’s medical device exports, but regulatory hurdles may pose an even bigger challenge. Can ...

The FDA has granted approval for Revvity’s Auto-Pure 2400 liquid handling platform, used in conjunction with the T-SPOT.TB ...

Global development program for JNJ-1900 (NBTXR3) proceeding as planned, with opportunity to address one of the largest untapped markets in ...